- Home
- PYPD vs NMTC Comparison
PYPD vs NMTC Comparison
Compare PYPD & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- NMTC
- Stock Information
- Founded
- PYPD 2008
- NMTC 2009
- Country
- PYPD Israel
- NMTC United States
- Employees
- PYPD N/A
- NMTC N/A
- Industry
- PYPD Medical/Dental Instruments
- NMTC Medical/Dental Instruments
- Sector
- PYPD Health Care
- NMTC Health Care
- Exchange
- PYPD Nasdaq
- NMTC Nasdaq
- Market Cap
- PYPD 19.4M
- NMTC 21.0M
- IPO Year
- PYPD 2020
- NMTC N/A
- Fundamental
- Price
- PYPD $3.30
- NMTC $1.05
- Analyst Decision
- PYPD Strong Buy
- NMTC
- Analyst Count
- PYPD 2
- NMTC 0
- Target Price
- PYPD $10.50
- NMTC N/A
- AVG Volume (30 Days)
- PYPD 49.0K
- NMTC 210.9K
- Earning Date
- PYPD 02-12-2025
- NMTC 02-11-2025
- Dividend Yield
- PYPD N/A
- NMTC N/A
- EPS Growth
- PYPD N/A
- NMTC N/A
- EPS
- PYPD N/A
- NMTC N/A
- Revenue
- PYPD N/A
- NMTC $3,453,003.00
- Revenue This Year
- PYPD N/A
- NMTC $292.88
- Revenue Next Year
- PYPD N/A
- NMTC N/A
- P/E Ratio
- PYPD N/A
- NMTC N/A
- Revenue Growth
- PYPD N/A
- NMTC 1.33
- 52 Week Low
- PYPD $2.37
- NMTC $0.55
- 52 Week High
- PYPD $7.00
- NMTC $1.59
- Technical
- Relative Strength Index (RSI)
- PYPD 55.20
- NMTC 61.82
- Support Level
- PYPD $2.93
- NMTC $1.00
- Resistance Level
- PYPD $3.35
- NMTC $1.28
- Average True Range (ATR)
- PYPD 0.24
- NMTC 0.13
- MACD
- PYPD 0.04
- NMTC 0.01
- Stochastic Oscillator
- PYPD 93.15
- NMTC 56.19
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.